Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 461-464

  Hanazaki, Kazuhiro ^a   Kajikawa, Shoji ^a   Fujimori, Yoshiro ^a   Nakata, Shinji ^a   Shimozawa, Nobuhiko ^a   Koide, Naohiko ^a   Adachi, Wataru ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver cirrhosis; Pringle maneuver; Prostaglandin E1

Indexed keywords

BILIRUBIN; CREATININE; PROSTAGLANDIN E1; UREA;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; MALE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LIVER TUMOR; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

AGED; ALPROSTADIL; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0033625069     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 1 Sinclair S, Levy G: Eicosanoids and the liver. Ital J Gastroenterol 1990; 22:205-213.
2. 2 Tojimbara S, Ohsaki S, Teraoka S, Takahashi K, Kawai T, Toma H, Agishi T, Ota K: Effects of prostaglandin E1 transplanted kidneys in dogs by laser Doppler blood perfusion monitor. Transplant Proc 1992; 24:1349-1350.
3. 3 Totsuka E, Sasaki M, Takahashi K, Toyoshi Y, Seino K, Hakamada K, Konn M: The effect of intraportal PGE1 on warm ischemic liver damage. Surg Today 1994; 24:1028-1030.
4. 4 Masaki N, Ohta Y, Shirataki H, Ogata I, Hayashi S, Yamada S, Hirata K, Nagoshi S, Mochida S, Tomiya T, Ohno A, Ohta Y, Fujiwara K: Hepatocyte membrane stabilization by prostaglandin E1 and E2: Favorable effects on rat liver injury. Gastroenterology 1992; 102:572-576.
5. 5 Mizoguchi Y, Tsutsui H, Miyojima K, Sakagami Y, Seki S, Kobayashi K, Yamamoto S, Morisawa S: The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 1987; 7:1184-1187.
6. 6 Helling TS, Hacker KA, Kragel PJ, Einstein CL: Evidence for cytoprotection by prostaglandin E1 with normothermic hepatic ischemia. J Surg Res 1994; 56:309-313.
7. 7 Hanazaki K, Kuroda T, Kajikawa S, Shiohara E, Haba Y, Iida F: Prostaglandin E1 protects liver from ischemic damage. J Surg Res 1994; 57:380-384.
8. 8 Klein AS, Coffer JB, Pruett TL, Thuluvath PJ, McGory R, Uber L, Stevenson WC, Baliga P, Burdick JF: Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial. Gastroenterology 1996; 111:710-715.
9. 9 Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MFX, Langer B, Levy GA: Treatment of primary liver graft non-function with prostaglandin E1. Transplantation 1989; 48:447-453.
10. 10 Xu HS, Rosenlof LK, Pruett TL, Jones RS: Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg 1994; 220:53-58.
11. 11 Henley KS, Lucey MR, Normolle DP, Merion RM, McLaren ID, Crider BA, Mackie DS, Shieck VL, Nostrant TT, Brown KA, Campbell DA, Ham JM, Appelman HD, Turcotte JG: A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology 1995; 21:366-372.
12. 12 Tanabe G, Aikou T, Kurita K, Kobayashi Y, Ueno S, Mitue S, Hamanoue M, Kawaida K, Ogura Y, Yoshidome S: Effects of exogenous prostaglandin E1 in hepatectomized patients. J Hep Bil Pancr Surg 1994; 4:402-405.
13. 13 Aono T, Sakaguchi T, Tsukada K, Shirai Y, Hatakeyama K: Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection. Dig Dis Sci 1996; 41:126-130.
14. 14 Makuuchi M, Takayama T, Kosuge S, Yamazaki S, Yamamoto J, Hasegawa H, Takayasu K: The value of ultrasonography for hepatic surgery. Hepatogastroenterology 1991; 38:64-70.
15. 15 Pringle JH: Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48:541-549.
16. 16 Shimada M, Matsumata T, Shirabe K, Sugimachi K: A thromboxane A2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy. Surgery 1993; 114:993-995.
17. 17 Humberg M, Svensson I, Samuelsson B: Thromboxane: a new group of biologically active compounds derived from prostaglandin endoperoxide. Proc Natl Acad Sci 1975; 72:2994-2998.
18. 18 Zipser RD, Radvan GH, Kronberg IJ: Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasodilator factors. Gastroenterology 1983; 84:697-703.
19. 19 Hanazaki K, Kuroda T, Kajikawa S: Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion. Hepatogastroenterology (In press)
20. 20 Shirabe K, Takenaka K, Yamamoto K, Kitamura M, Itasaka H, Matsumata T, Shimada M, Sugimachi K: The role of prostanoid in hepatic damage during hepatectomy. Hepatogastroenterology 1996; 43:596-601.
21. 21 Hanazaki K, Kuroda T, Haba Y, Shiohara E, Kajikawa S, Iida F: Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. Surgery 1994; 116:896-903.
22. 22 Beck PL, McKnight GW, Kelly JK: Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology 1993; 105:1483-1489.
23. 23 Makowka L, Lopatin W, Gilas T, Falk J, Phillips MJ, Falk R: Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins. Clin Nephrol 1986; 25(Suppl 1):S 89-94.
24. 24 Perico N, Dadan J, Remuzzi G: Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1991; 1: 76.